Today: 17 May 2026
Browse Category

NASDAQ:NOKIA 26 April 2026

Nokia Oyj Stock Faces a Fresh Test After AI Orders Light Up Earnings

Nokia Oyj Stock Faces a Fresh Test After AI Orders Light Up Earnings

Nokia shares will trade ex-dividend on April 27 after first-quarter operating profit jumped 54% to 281 million euros, beating analyst forecasts. AI and cloud customers accounted for 8% of sales, with orders from that segment rising 49% to 1 billion euros. U.S.-listed ADRs closed at $10.46 on Friday, up 1.2%. Nokia maintained its full-year profit target.
26 April 2026
·····

Stock Market Today

  • GrainCorp Shares Slide After Weak H1 Earnings, Valuation Down 29.9%
    May 16, 2026, 9:02 PM EDT. GrainCorp (ASX:GNC) reported sharply weaker profit and EBITDA for the first half of 2026, triggering a 3.16% drop in its share price to A$5.21. The stock's 7-day decline stands at 14.59%, with a year-to-date drop of 27.74%. Despite short-term weakness, the 5-year total shareholder return remains positive at 41.23%. Management maintains full-year guidance and dividends. Analysts see the stock as potentially undervalued by 29.9%, with a fair value estimate of A$7.44 based on a cash flow and earnings forecast. A business transformation program, including an SAP system upgrade, aims to unlock $20-30 million in efficiencies to improve margins. Key risks include weather impacts on grain volumes and global freight cost pressures. Investors face mixed sentiment as they assess risks and opportunities.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Go toTop